Galeopterus variegatus (Sunda flying lemur): 103589530
Help
Entry
103589530 CDS
T08727
Symbol
CASP3
Name
(RefSeq) caspase-3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
gvr
Galeopterus variegatus (Sunda flying lemur)
Pathway
gvr01524
Platinum drug resistance
gvr04010
MAPK signaling pathway
gvr04115
p53 signaling pathway
gvr04148
Efferocytosis
gvr04210
Apoptosis
gvr04215
Apoptosis - multiple species
gvr04623
Cytosolic DNA-sensing pathway
gvr04650
Natural killer cell mediated cytotoxicity
gvr04657
IL-17 signaling pathway
gvr04668
TNF signaling pathway
gvr04726
Serotonergic synapse
gvr04932
Non-alcoholic fatty liver disease
gvr04933
AGE-RAGE signaling pathway in diabetic complications
gvr04936
Alcoholic liver disease
gvr05010
Alzheimer disease
gvr05012
Parkinson disease
gvr05014
Amyotrophic lateral sclerosis
gvr05016
Huntington disease
gvr05020
Prion disease
gvr05022
Pathways of neurodegeneration - multiple diseases
gvr05132
Salmonella infection
gvr05133
Pertussis
gvr05134
Legionellosis
gvr05145
Toxoplasmosis
gvr05146
Amoebiasis
gvr05152
Tuberculosis
gvr05160
Hepatitis C
gvr05161
Hepatitis B
gvr05162
Measles
gvr05163
Human cytomegalovirus infection
gvr05164
Influenza A
gvr05165
Human papillomavirus infection
gvr05167
Kaposi sarcoma-associated herpesvirus infection
gvr05168
Herpes simplex virus 1 infection
gvr05169
Epstein-Barr virus infection
gvr05170
Human immunodeficiency virus 1 infection
gvr05200
Pathways in cancer
gvr05203
Viral carcinogenesis
gvr05205
Proteoglycans in cancer
gvr05206
MicroRNAs in cancer
gvr05210
Colorectal cancer
gvr05222
Small cell lung cancer
gvr05416
Viral myocarditis
gvr05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
gvr00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
103589530 (CASP3)
04668 TNF signaling pathway
103589530 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
103589530 (CASP3)
09143 Cell growth and death
04210 Apoptosis
103589530 (CASP3)
04215 Apoptosis - multiple species
103589530 (CASP3)
04115 p53 signaling pathway
103589530 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
103589530 (CASP3)
04650 Natural killer cell mediated cytotoxicity
103589530 (CASP3)
04657 IL-17 signaling pathway
103589530 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
103589530 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
103589530 (CASP3)
05206 MicroRNAs in cancer
103589530 (CASP3)
05205 Proteoglycans in cancer
103589530 (CASP3)
05203 Viral carcinogenesis
103589530 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
103589530 (CASP3)
05222 Small cell lung cancer
103589530 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
103589530 (CASP3)
05161 Hepatitis B
103589530 (CASP3)
05160 Hepatitis C
103589530 (CASP3)
05164 Influenza A
103589530 (CASP3)
05162 Measles
103589530 (CASP3)
05168 Herpes simplex virus 1 infection
103589530 (CASP3)
05163 Human cytomegalovirus infection
103589530 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
103589530 (CASP3)
05169 Epstein-Barr virus infection
103589530 (CASP3)
05165 Human papillomavirus infection
103589530 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
103589530 (CASP3)
05133 Pertussis
103589530 (CASP3)
05134 Legionellosis
103589530 (CASP3)
05152 Tuberculosis
103589530 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
103589530 (CASP3)
05145 Toxoplasmosis
103589530 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
103589530 (CASP3)
05012 Parkinson disease
103589530 (CASP3)
05014 Amyotrophic lateral sclerosis
103589530 (CASP3)
05016 Huntington disease
103589530 (CASP3)
05020 Prion disease
103589530 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
103589530 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
103589530 (CASP3)
05416 Viral myocarditis
103589530 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
103589530 (CASP3)
04932 Non-alcoholic fatty liver disease
103589530 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
103589530 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
103589530 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
gvr01002
]
103589530 (CASP3)
Enzymes [BR:
gvr01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
103589530 (CASP3)
Peptidases and inhibitors [BR:
gvr01002
]
Cysteine peptidases
Family C14: caspase family
103589530 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Peptidase_C14
SICA_beta
Motif
Other DBs
NCBI-GeneID:
103589530
NCBI-ProteinID:
XP_008569758
LinkDB
All DBs
Position
Unknown
AA seq
277 aa
AA seq
DB search
MENTENSVDSKSFKNLGTEIIHGSQSVGSGICLDDSYKMDYPEMGLCIIINNKNFDQSTG
MSPRIGTDVDAASLREIFMNLKYEVRNKNDLTCEEILELMRNVSKEDHSKRSSFICVILS
HGEEGVIFGTNGPIDLRKLTILFRGDYCRSLTGKPKLFIIQACRGRELDCGIETDSGTDD
EMMCQKIPVEADFLYAYSTAPGYYSWRNSTHGSWFIQALCALLKMYAHKLEFVHILTRVN
QKVATEFQSISEKSEYHAKKQIPCIVSMLTKELYFYH
NT seq
834 nt
NT seq
+upstream
nt +downstream
nt
atggagaacactgaaaactcagtggattcaaaatcctttaaaaatttgggaacagagatc
atacatggaagccagtcagtgggctctggaatatgcttggatgatagctacaaaatggat
tatcctgaaatgggtttatgtataataattaataataagaactttgatcaaagcactgga
atgagtcctcggattggtaccgatgtagatgcagcaagcctcagggaaatattcatgaac
ttgaaatacgaagtcaggaataaaaatgatcttacatgtgaagaaattttggaattgatg
cgcaatgtttctaaagaagatcatagcaaaaggagcagttttatttgtgtgattctaagc
catggtgaagaaggagtaatttttggaacaaatggacctattgacctgagaaaattaaca
attttgttcagaggggattattgtagaagtctaactggaaaacccaaacttttcattatc
caggcctgccgaggtagagaactggactgtggcatcgagacagacagtggtactgatgat
gagatgatgtgtcagaaaataccagttgaggccgacttcttgtatgcgtattccacagca
cctggttattattcctggcgaaattcaacacatggatcctggttcatccaggcactttgt
gctttgctgaaaatgtacgcccacaagcttgagttcgtgcacattcttacccgggttaac
caaaaggtagcaacagaatttcagtccattagcgagaaatctgagtatcatgcaaaaaaa
caaattccttgtattgtgtccatgctcacaaaagaactgtatttttaccactaa
DBGET
integrated database retrieval system